Details of the Drug Formulaction

General Information of Drug Formulation (ID: F12691)

Formulation Name

Lubiprostone 0.024 mg capsule

Company

Takeda Pharmaceuticals America

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lubiprostone	DMJTEMW	Chronic idiopathic constipation	DC32	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	E00338	33258	Colorant
Hexahydric alcohol	E00083	5780	Diluent; Flavoring agent; Humectant; Plasticizing agent
Medium-chain triglyceride	E00640	Not Available	Emollient; Lubricant; Surfactant
Quinoline yellow WS	E00309	24671	Colorant
Water	E00035	962	Solvent

--------------------